CIDP Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

IVIG vs SCIG in CIDP
Conditions:   CIDP;   Immunoglobulin Deficiency;   Chronic Inflammatory Demyelinating Polyneuropathy Interventions:   Drug: Intravenous immune globulin G;   Drug: Subcutaneous immune globulin G Sponsor:   Rutgers, The State University of New Jersey Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2022 Category: Research Source Type: clinical trials

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Condition:   Chronic Inflammatory Demyelinating Polyneuropathy Interventions:   Drug: Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly;   Drug: Batoclimab 340 mg SC weekly;   Drug: Placebo Sponsor:   Immunovant Sciences GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials